A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2024, filed Jul 8, 2024. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FRSPF SEC filings page.
This page shows FIRST PHOSPHATE CORP (FRSPF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
FIRST PHOSPHATE CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
FIRST PHOSPHATE CORP reported a net loss of $6.1M while operations used $2.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
FIRST PHOSPHATE CORP reported a net loss of $6.1M in fiscal year 2024. The change from the prior year is not meaningful, because that figure was zero or negative.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
Cash & Balance Sheet
FIRST PHOSPHATE CORP held $5.5M in cash as of fiscal year 2024; no long-term debt figure is on record for that period.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
Margins & Returns
FIRST PHOSPHATE CORP's ROE was -89.0% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 30.3 percentage points from the prior year.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
Capital Allocation
FIRST PHOSPHATE CORP invested $320K in research and development in fiscal year 2024.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
FRSPF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, EPS (Diluted), Diluted Shares (Avg).
FRSPF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
FRSPF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Free Cash Flow, Dividends Paid, Share Buybacks.
FRSPF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Debt-to-Equity, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| FIRST PHOSPHATE CORP FRSPF | FY2024 | N/A | -$6.1M | N/A | $227.0M | — |
| INTERNATIONAL BAT MET IBATF | FY2026 | $164K | $122K | 74.4% | $24.4M | — |
Where FIRST PHOSPHATE CORP Ranks
Frequently Asked Questions
Is FIRST PHOSPHATE CORP profitable?
No, FIRST PHOSPHATE CORP (FRSPF) reported a net loss of $6.1M in fiscal year 2024.
What is FIRST PHOSPHATE CORP's return on equity (ROE)?
FIRST PHOSPHATE CORP (FRSPF) has a return on equity of -89.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is FIRST PHOSPHATE CORP's operating cash flow?
FIRST PHOSPHATE CORP (FRSPF) recorded an outflow of $2.7M in operating cash flow during fiscal year 2024, representing cash used by core business activities.
What are FIRST PHOSPHATE CORP's total assets?
FIRST PHOSPHATE CORP (FRSPF) had $9.6M in total assets as of fiscal year 2024, including both current and long-term assets.
How much does FIRST PHOSPHATE CORP spend on research and development?
FIRST PHOSPHATE CORP (FRSPF) invested $320K in research and development during fiscal year 2024.
What is FIRST PHOSPHATE CORP's liabilities-to-equity ratio?
FIRST PHOSPHATE CORP (FRSPF) had a liabilities-to-equity ratio of 0.40 as of fiscal year 2024, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2024, because the filing data we hold for that year carries no long-term debt figure.
What is FIRST PHOSPHATE CORP's return on assets (ROA)?
FIRST PHOSPHATE CORP (FRSPF) had a return on assets of -63.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is FIRST PHOSPHATE CORP's P/E ratio?
FIRST PHOSPHATE CORP (FRSPF) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2024). The market capitalization is $227.0M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is FIRST PHOSPHATE CORP's price-to-sales ratio?
FIRST PHOSPHATE CORP (FRSPF) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $227.0M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Are FIRST PHOSPHATE CORP's earnings high quality?
FIRST PHOSPHATE CORP (FRSPF) reported a net loss of $6.1M while operations used $2.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.